Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

August 19, 2021

Study Completion Date

August 19, 2021

Conditions

Breast CancerHealthy Volunteers

Interventions

DRUG

amcenestrant

Tablet Oral

DRUG

[14C]-SAR439859 microtracer

Solution for infusion Intravenous

DRUG

[14C]-SAR439859

Powder for oral solution Oral

Trial Locations (1)

Investigational Site Number 8260001, Nottingham